Please ensure Javascript is enabled for purposes of website accessibility

EPA Releases List of Disinfectants to Protect Against Coronavirus

By Eric Volkman - Mar 6, 2020 at 10:04AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're trying to prevent the spread of SARS-CoV-2, the cause of COVID-19, products from Clorox and Ecolab, among others, will kill the virus on surfaces.

The Centers for Disease Control and a host of other medical organizations worldwide have lately been publicizing a number of measures people can take to reduce their chances of infection from SARS-CoV-2, the coronavirus that causes COVID-19. Wash your hands frequently, shun handshakes, and stop touching your face, they all agree. And, they say, clean all "high-touch" surfaces daily. 

Well, now we also know which products we ought to be cleaning those surfaces with. The Environmental Protection Agency on Thursday released a long list of disinfectant products that are known to be effective virus killers.

"Using the correct disinfectant is an important part of preventing and reducing the spread of illnesses along with other critical aspects such as hand washing," the EPA said in its announcement.

A cleaning product being sprayed onto a glass surface.

Image source: Getty Images

The six-page long list includes 13 products made by Clorox (CLX 0.59%), including Clorox Disinfecting Wipes and the company's Multi-Surface Cleaner + Bleach. Seven products made by Ecolab also appear in the lineup, among them Oxycide Daily Disinfectant Cleaner and Virasept.

The EPA said that all the listed products are effective in the fight against harder-to-kill viruses than the coronavirus now spreading around the world. According to the Agency, coronaviruses fall into a category known as enveloped viruses -- one of the easiest virus forms to kill with a sufficiently strong disinfectant.

Whichever products from the list you use, the EPA recommends that people closely follow their instructions for use, particularly in regards to how long the cleaner should be left on a treated surface before removal in order to ensure effective disinfection.

Meanwhile, a number of pharmaceutical companies and biotechs continue to work toward finding vaccines and treatments. Gilead Sciences (GILD -0.03%), for one, is hoping to repurpose one of its previously developed antiviral drugs for this outbreak. Getting the necessary data to show whether it's effective against SARS-CoV-2 has been a struggle, though -- according to media reports, Gilead has had difficulty finding enough test subjects for clinical trials in China.

On Thursday, when the S&P 500 slid by 2.9%, Clorox stock rose by nearly 2%, shares of Ecolab slumped by almost 3%, and Gilead stock closed the day essentially flat. 

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Gilead Sciences, Inc. Stock Quote
Gilead Sciences, Inc.
GILD
$62.34 (-0.03%) $0.02
The Clorox Company Stock Quote
The Clorox Company
CLX
$144.75 (0.59%) $0.85
Ecolab Inc. Stock Quote
Ecolab Inc.
ECL
$158.02 (0.22%) $0.35

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.